Cover Image


Vaccine Delivery Markets for Microneedle Devices

出版商 Greystone Research Associates 商品編碼 428083
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
微針頭設備疫苗輸送市場 Vaccine Delivery Markets for Microneedle Devices
出版日期: 2017年01月30日 內容資訊: 英文




  • 全球疫苗統計
  • 感染疾病的地區性要素
    • 國民意識 & 教育
    • 個人衛生、地方文化
    • 獲得醫療保健
  • 疫苗接種、公共健康要素
    • 醫療保險
    • 保存、有效期限
    • 免疫抗原性
    • 給藥頻率
    • 患者態度、誤解
    • 患者/看護者的安全性 & 設備的廢棄

皮內/經皮投藥的促進要素 & 推動力

  • 罹患率 & 死亡率
  • 疫苗給藥候補
  • NGO的資金援助計劃
  • 政府的技術轉移計劃

微針頭設備 - 設計 & 技術

  • 微針頭的種類
  • 微針頭產品的分類
    • 注射器取付型微針頭
    • 貼片、戳型陣列
  • 微針頭製造
    • 材料選擇的課題
    • 製造技術


  • 認證產品
    • 產品開發
    • 臨床開發:各國各地區


  • 潛在市場
    • 治療
    • 地區
    • 官方/民間計劃 & 倡議
    • 疫苗供應商/設備開發者的合作


  • 疾病標的發展
  • 新/改性疫苗
  • 法規問題
  • NGO的重要角色
  • 管理護理
  • 臨床實驗要素


Product Code: FVDM899F17

Safety and Simplicity

Vaccines are recognized as one of the most significant healthcare developments in the last one hundred years. In spite of their role in improving quality-of-life and drastically reducing the level of morbidity and mortality from infectious diseases, the ability of healthcare and state institutions to maximize access to many millions of underserved people has still not been realized. This is a complex picture that is characterized by significant regional and socioeconomic factors. One major obstacle is cost, particularly for many underdeveloped countries. Microneedle technology, which has been successfully used to delivery therapeutic drugs, continues to be investigated as a vaccine delivery method. The relative simplicity and safety of microneedles makes them well-suited for use in mass immunization as well as for single patients. Numerous companies are currently involved in clinical development to identify the true potential of this technology.

What You Will Learn

  • What prophylactic vaccines are currently approved or in development for administration via microneedle devices?
  • What are the key public health factors associated with addressing the unmet need for vaccination?
  • What are the key factors that are influencing demand for vaccine delivery via microneedles ?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for microneedle devices that deliver vaccines?
  • What is the addressable market for vaccines that are supplied for microneedle delivery?
  • What are the significant regional economic and regulatory factors that will influence efforts to commercialize microneedle-administered vaccines?

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

‘Of the handful of prophylactic vaccines that have received regulatory approval for administration via microneedle delivery devices, the leading technology to date is clearly syringe-mounted microneedles, featuring either a single microneedle or a small array of several microneedles. These devices can be considered the first generation of devices for vaccine administration. Patch and stamp type devices featuring larger arrays, while under investigation, will likely eventually play a role in niche markets '

Table of Contents

Executive Summary

The Vaccine Administration Market Opportunity

  • Global Vaccine Demographics
  • Regional Factors in Infectious Disease
    • Public Awareness & Education
    • Personal Hygiene and Local Cultures
    • Access to Healthcare
  • Vaccination and Public Health Factors
    • Healthcare Infrastructure
    • Storage and Shelf Life
    • Immunogenicity
    • Dosing Frequency
    • Patient Attitudes and Misconceptions
    • Patient/Caregiver Safety & Device Disposal

Intradermal/Transcutaneous Dosing Drivers & Enablers

  • Morbidity & Mortality
  • Vaccine Dose Sparing
  • NGO Funding Programs
  • Government Technology Transfer Programs

Microneedle Devices - Design & Technology

  • Microneedle Types
  • Microneedle Product Categories
    • Syringe-mounted Microneedles
      • Single Needles
      • Multiple Needles
    • Patch and Stamp Type Arrays
  • Microneedle Manufacturing
    • Material Selection Issues
    • Fabrication Techniques

The Current Landscape

  • Approved Products
    • Product Development
      • Vaccines
      • Devices
      • Combination Products
    • Clinical Development by Country/Region

The Market Picture to 2022

  • Addressable Markets
    • Therapeutic
      • Acute Infection
      • Chronic Infection
      • Seasonal Infection
    • Geographic
      • Developed Economies
      • Emerging Regions
      • Underdeveloped Regions
    • Public/Private Programs & Initiatives
    • Vaccine Supplier/Device Developer Collaborations

Vaccine Delivery Markets - Market Factors

  • Evolving Disease Targets
  • New/Reformulated Vaccines
  • Regulatory Issues
  • The Critical Role of NGOs
  • Managed Care
  • Clinical Trial Factors

Company Profiles

Back to Top